A monoclonal antibody-linked immunoassay for hemoglobin H disease

Area of Science:

• Hematology
• Immunology
• Molecular Biology

Background:

• Hemoglobin H (Hb H) disease is a genetic disorder characterized by the abnormal tetrameric form of beta-globin chains (β4).
• Accurate detection and quantification of Hb H are crucial for diagnosing and managing Hb H disease.
• Existing diagnostic methods may lack the sensitivity or specificity required for precise Hb H measurement.

Purpose of the Study:

• To develop and validate a sensitive enzyme immunoassay for detecting and quantifying Hb H in patient hemolysates.
• To assess delta globin levels in individuals with Hb H disease using a specific monoclonal antibody.
• To elucidate the molecular mechanisms underlying Hb H disease through the analysis of globin chain expression.

Main Methods:

• Generation of a murine monoclonal antibody (mAb) specifically recognizing the tetrameric form of human beta-globin chains (Hb H).
• Establishment of a rapid and sensitive enzyme immunoassay using the anti-Hb H mAb for quantification.
• Utilized a second mAb (delta-1) specific for delta chains of Hb A2 to measure delta globin levels.

Main Results:

• The developed immunoassay accurately detected and quantified Hb H, with levels ranging from 1.5% to 25% in patients with Hb H disease.
• A significant average reduction (32%) in delta globin chains was observed in Hb H disease patients compared to normal adults.
• The study confirmed that decreased alpha chain expression leads to reduced levels of Hb A and Hb A2, with subsequent accumulation of Hb H.

Conclusions:

• The novel enzyme immunoassay provides a sensitive and specific tool for diagnosing and monitoring Hb H disease.
• Reduced delta globin levels are a characteristic finding in Hb H disease, contributing to the altered globin chain composition.
• The findings reinforce the understanding of alpha-thalassemia's role in the pathogenesis of Hb H disease, highlighting globin chain imbalance.